INTERNATIONAL PATENT: TESSERA THERAPEUTICS, INC. FILES APPLICATION FOR "SITE-SPECIFIC CONJUGATION OF TARGETING MOIETIES TO LIPID NANOPARTICLES"

GENEVA, Sept. 18 -- TESSERA THERAPEUTICS, INC. (101 South Street, Suite 300Somerville, Massachusetts 02143) filed a patent application (PCT/US2025/019040) for "SITE-SPECIFIC CONJUGATION OF TARGETING MOIETIES TO LIPID NANOPARTICLES" on Mar 07, 2025. With publication no. WO/2025/189161, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PALCHAUDHURI, Rahul (c/o Tessera Therapeutics, Inc.101 South Street, Suite 300Somerville, Massachusetts 02143), MONTE, Michael, Tobias (c/o Tessera Therapeutics, Inc.101 South Street, Suite 300...